Internal Medicine, Critical Care Medicine · Terre Haute, IN
NPI
1922116672
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1429 N 6th St
Terre Haute, IN, 47807
Phone (812) 242-3109
Groups this clinician bills Medicare through
Medicare paid, 2024
$244K
3,690 services
Medicare patients, 2024
1,125
Average age 74
Drug cost, 2024
$3.4M
1,710 prescriptions
Company payments, 2025
$1,833
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shashikumar R Gowda was code 94729 (pulmonary function testing), 482 times for 308 patients. In total Shashikumar R Gowda billed 3,690 services in 36 codes, and Medicare paid $244K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94729 Pulmonary Function Testing | Office | 482 | 308 | $21.20 | $10K |
| 94727 Pulmonary Function Testing | Office | 468 | 295 | $16.72 | $7,826 |
| 99232 Hospital E&M - Subsequent | Facility | 468 | 182 | $57.92 | $27K |
| 94060 Pulmonary Function Testing | Office | 464 | 296 | $14.69 | $6,814 |
| 99291 Critical Care E&M | Facility | 438 | 196 | $152.93 | $67K |
| 99214 Office E&M - Established | Office | 191 | 142 | $90.18 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 169 | 111 | $87.23 | $15K |
| 99223 Hospital E&M - Initial | Facility | 167 | 158 | $126.20 | $21K |
| 99213 Office E&M - Established | Office | 163 | 139 | $60.22 | $9,816 |
| 95810 Sleep Study | Office | 108 | 65 | $210.35 | $23K |
| 95806 Sleep Study | Office | 80 | 51 | $29.30 | $2,344 |
| 95811 Sleep Study | Office | 74 | 42 | $233.07 | $17K |
| 99222 Hospital E&M - Initial | Facility | 65 | 56 | $95.86 | $6,231 |
| 95012 Pulmonary | Office | 56 | 56 | $12.62 | $707 |
| 94060 Pulmonary Function Testing | Facility | 49 | 49 | $7.55 | $370 |
By year: 2022 $336K for 5,388 services; 2023 $298K for 4,642 services; 2024 $244K for 3,690 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shashikumar R Gowda prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 265 prescriptions and refills. In total Shashikumar R Gowda wrote 1,710 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 265 | 378 | 68 | $237K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 257 | 316 | 82 | $6,096 |
| Breo Ellipta Fluticasone/Vilanterol | 76 | 100 | 20 | $39K |
| Orenitram Er Treprostinil Diolamine | 73 | 73 | Under 11 | $510K |
| Montelukast Sodium Generic | 69 | 134 | 18 | $563 |
| Symbicort Budesonide/Formoterol Fumarate | 66 | 114 | 23 | $26K |
| Ofev Nintedanib Esylate | 65 | 65 | Under 11 | $825K |
| Spiriva Respimat Tiotropium Bromide | 60 | 114 | 18 | $60K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 53 | 87 | 16 | $41K |
| Prednisone Generic | 52 | 65 | 37 | $152 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 49 | 65 | 16 | $5,149 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 41 | 46 | Under 11 | $29K |
| Opsumit Macitentan | 38 | 38 | Under 11 | $505K |
| Dupixent Pen Dupilumab | 37 | 37 | Under 11 | $137K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 36 | 46 | 15 | $6,956 |
Brand drugs: 1,240 claims; generic drugs: 470 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shashikumar R Gowda $1,833 ($1,833 in general payments such as food, travel and fees) from 18 companies. The largest payer was Olympus Corporation of the Americas with $464.
| Company | Payments | Amount |
|---|---|---|
| Olympus Corporation of the Americas | 2 | $464 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $325 |
| Harmony Biosciences LLC HRMY | 6 | $285 |
| GlaxoSmithKline, LLC. GSK | 22 | $195 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $113 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $81.54 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $49.84 |
| Axsome Therapeutics, Inc. AXSM | 2 | $43.04 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $35.56 |
| Merck Sharp & Dohme LLC MRK | 2 | $34.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.